Medicine
Diltiazem 360 mg extended-release capsule
Diltiazem 360 mg extended-release capsule is a generic prescription medicine for oral use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C…
Key facts
- Active ingredient (INN)
- Diltiazem
- Brand
- Sold under the generic name
- Strength
- 360 mg
- Dosage form
- Extended-release capsule
- Route
- Oral
- Packs
- 500 capsules, 1000 capsules, 90 capsules and 42 more
- Manufacturers
- Sun Pharmaceutical IndustriesIndiaZydus LifesciencesIndiaAlembic PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaIngenus PharmaceuticalsUpsher-Smith LaboratoriesActavis PharmaOceanside Pharmaceuticals10 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C (59° and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C05AE03 Diltiazem
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 November 2010
- Identifiers
- RxCUI 830795, 830801, 830837 +3DailyMed set ID eebf29fe-ce22-4482-b850-5854550bf2c4, 6f71ba5e-7bd6-409a-80c6-2f22d975aefc, 850566b1-0c8e-42bc-85fa-c8ee710f34ba +12NDC 47335-673, 47335-679, 33342-525 +12Application ANDA090421, ANDA090492, ANDA218744 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 10 labelers. The register lists 45 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 500 capsule, extended release in 1 bottle | 47335-673-13 | Sun Pharmaceutical IndustriesIndia | 15 November 2010 |
| 1000 capsule, extended release in 1 bottle | 47335-673-18 | Sun Pharmaceutical IndustriesIndia | 15 November 2010 |
| 90 capsule, extended release in 1 bottle | 47335-673-19 | Sun Pharmaceutical IndustriesIndia | 15 November 2010 |
| 90 capsule, extended release in 1 bottle | 47335-673-81 | Sun Pharmaceutical IndustriesIndia | 15 November 2010 |
| 30 capsule, extended release in 1 bottle | 47335-673-83 | Sun Pharmaceutical IndustriesIndia | 15 November 2010 |
| 500 capsule, extended release in 1 bottle | 47335-679-13 | Sun Pharmaceutical IndustriesIndia | 31 October 2011 |
| 1000 capsule, extended release in 1 bottle | 47335-679-18 | Sun Pharmaceutical IndustriesIndia | 31 October 2011 |
| 90 capsule, extended release in 1 bottle | 47335-679-19 | Sun Pharmaceutical IndustriesIndia | 31 October 2011 |
| 90 capsule, extended release in 1 bottle | 47335-679-81 | Sun Pharmaceutical IndustriesIndia | 31 October 2011 |
| 30 capsule, extended release in 1 bottle | 47335-679-83 | Sun Pharmaceutical IndustriesIndia | 31 October 2011 |
| 500 capsule, extended release in 1 bottle | 63304-722-05 | Sun Pharmaceutical IndustriesIndia | 31 October 2018 |
| 30 capsule, extended release in 1 bottle | 63304-722-30 | Sun Pharmaceutical IndustriesIndia | 31 October 2018 |
| 90 capsule, extended release in 1 bottle | 63304-722-90 | Sun Pharmaceutical IndustriesIndia | 31 October 2018 |
| 30 capsule, extended release in 1 bottle | 46708-729-30 | Alembic PharmaceuticalsIndia | 14 November 2024 |
| 90 capsule, extended release in 1 bottle | 46708-729-90 | Alembic PharmaceuticalsIndia | 14 November 2024 |
| 1000 capsule, extended release in 1 bottle | 46708-729-91 | Alembic PharmaceuticalsIndia | 14 November 2024 |
| 30 capsule, extended release in 1 bottle | 62332-729-30 | Alembic PharmaceuticalsIndia | 14 November 2024 |
| 90 capsule, extended release in 1 bottle | 62332-729-90 | Alembic PharmaceuticalsIndia | 14 November 2024 |
| 1000 capsule, extended release in 1 bottle | 62332-729-91 | Alembic PharmaceuticalsIndia | 14 November 2024 |
| 100 capsule, extended release in 1 bottle | 68382-599-01 | Zydus LifesciencesIndia | 28 September 2017 |
| 500 capsule, extended release in 1 bottle | 68382-599-05 | Zydus LifesciencesIndia | 2 October 2018 |
| 30 capsule, extended release in 1 bottle | 68382-599-06 | Zydus LifesciencesIndia | 28 September 2017 |
| 90 capsule, extended release in 1 bottle | 68382-599-16 | Zydus LifesciencesIndia | 28 September 2017 |
| 10 blister pack in 1 carton / 10 capsule, extended release in 1 blister pack | 68382-599-77 | Zydus LifesciencesIndia | 28 September 2017 |
| 100 capsule, extended release in 1 bottle | 70771-1034-1 | Zydus LifesciencesIndia | 28 September 2017 |
| 30 capsule, extended release in 1 bottle | 70771-1034-3 | Zydus LifesciencesIndia | 28 September 2017 |
| 10 blister pack in 1 carton / 10 capsule, extended release in 1 blister pack | 70771-1034-4 | Zydus LifesciencesIndia | 28 September 2017 |
| 500 capsule, extended release in 1 bottle | 70771-1034-5 | Zydus LifesciencesIndia | 2 October 2018 |
| 90 capsule, extended release in 1 bottle | 70771-1034-9 | Zydus LifesciencesIndia | 28 September 2017 |
| 6 capsule, extended release in 1 blister pack | 33342-525-02 | Macleods PharmaceuticalsIndia | 23 June 2023 |
| 30 capsule, extended release in 1 bottle | 33342-525-07 | Macleods PharmaceuticalsIndia | 23 June 2023 |
| 90 capsule, extended release in 1 bottle | 33342-525-10 | Macleods PharmaceuticalsIndia | 23 June 2023 |
| 90 capsule, extended release in 1 bottle | 0228-2918-09 | Actavis Pharma | 25 November 2013 |
| 500 capsule, extended release in 1 bottle | 50742-252-05 | Ingenus Pharmaceuticals | 14 June 2019 |
| 1000 capsule, extended release in 1 bottle | 50742-252-10 | Ingenus Pharmaceuticals | 14 June 2019 |
| 30 capsule, extended release in 1 bottle | 50742-252-30 | Ingenus Pharmaceuticals | 14 June 2019 |
| 90 capsule, extended release in 1 bottle | 50742-252-90 | Ingenus Pharmaceuticals | 14 June 2019 |
| 90 capsule, extended release in 1 bottle, plastic | 68682-371-90 | Oceanside Pharmaceuticals | 20 August 2014 |
| 21000 capsule, extended release in 1 drum | 24979-030-00 | Upsher-Smith Laboratories | 1 July 2024 |
| 90 capsule, extended release in 1 bottle | 24979-030-07 | Upsher-Smith Laboratories | 1 October 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 5 November 1982 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Diltiazem 360 mg extended-release capsule.
Other strengths and forms of Diltiazem
Clinical summary
Diltiazem is a calcium channel blocker indicated for the management of chronic stable angina and angina due to coronary artery spasm. It is available as extended-release capsules, tablets and extended-release tablets for oral and intravenous use. MedsAcross supplies Diltiazem for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DiltiazemFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cardizem prescribing information (Bausch Health) · U.S. National Library of Medicine, DailyMed
Need Diltiazem 360 mg extended-release capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.